In patients with macroprolactinomas the PRL levels after treatment suspension were in the normal range; and in the latest control some patients, including the three patients with tumor persistence, showed slightly increased levels above the upper normal limit, this situation might be due to the effects of menopause. This evidence concerns the gene PRL and neoplasm.